Scarica l'app Stockscreener
1.16
4.98%
0.055
Dopo l'orario di chiusura:
1.14
-0.02
-1.72%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.105
Aprire:
$1.1
Volume 24 ore:
31,500
Relative Volume:
0.82
Capitalizzazione di mercato:
$13.43M
Reddito:
$996.00K
Utile/perdita netta:
$-6.09M
Rapporto P/E:
-2.1887
EPS:
-0.53
Flusso di cassa netto:
$-9.76M
1 W Prestazione:
+4.98%
1M Prestazione:
-1.69%
6M Prestazione:
+12.62%
1 anno Prestazione:
-32.16%
Intervallo 1D:
$1.0801
$1.16
Intervallo di 1 settimana:
$1.055
$1.16
Portata 52W:
$0.70
$2.44
Therapeuticsmd Inc Stock (TXMD) Company Profile
Nome
Therapeuticsmd Inc
Settore
Telefono
561-961-1900
Indirizzo
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Confronta TXMD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
1.16 | 12.50M | 996.00K | -6.09M | -9.76M | -0.53 |
|
ZTS
Zoetis Inc
|
152.44 | 66.04B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.77 | 45.57B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.69 | 42.50B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.21 | 18.84B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
309.72 | 13.59B | 2.99B | 1.21B | 1.13B | 25.06 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-08-07 | Downgrade | Jefferies | Hold → Underperform |
| 2020-05-19 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-12-02 | Iniziato | Guggenheim | Buy |
| 2019-10-17 | Iniziato | H.C. Wainwright | Buy |
| 2019-04-30 | Ripresa | Noble Capital Markets | Outperform |
| 2018-06-15 | Iniziato | JP Morgan | Overweight |
| 2017-09-08 | Iniziato | Morgan Stanley | Equal-Weight |
| 2017-07-11 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2017-05-09 | Downgrade | Oppenheimer | Outperform → Perform |
| 2016-11-22 | Ripresa | Jefferies | Buy |
| 2016-11-22 | Iniziato | Oppenheimer | Outperform |
| 2016-11-07 | Ripresa | Guggenheim | Buy |
| 2016-04-04 | Iniziato | Goldman | Buy |
| 2015-12-08 | Reiterato | Jefferies | Buy |
| 2015-12-08 | Reiterato | Stifel | Buy |
| 2015-09-21 | Reiterato | Jefferies | Buy |
| 2015-06-09 | Iniziato | Guggenheim | Buy |
| 2014-07-08 | Iniziato | FBR Capital | Outperform |
| 2014-04-17 | Reiterato | Noble Financial | Buy |
| 2014-01-28 | Reiterato | Noble Financial | Buy |
Mostra tutto
Therapeuticsmd Inc Borsa (TXMD) Ultime notizie
Can volume confirm reversal in TherapeuticsMD Inc.Recession Risk & Technical Pattern Recognition Alerts - Newser
Using fundamentals and technicals on TherapeuticsMD Inc.2025 Market Trends & Weekly Watchlist for Hot Stocks - Newser
What’s the recovery path for long term holders of TherapeuticsMD Inc.July 2025 Highlights & Free Low Drawdown Momentum Trade Ideas - Newser
What makes TherapeuticsMD Inc. stock price move sharplyJuly 2025 Institutional & Consistent Profit Alerts - Newser
TherapeuticsMD: Q2 Earnings Snapshot - New Haven Register
Published on: 2025-08-13 05:39:11 - Newser
Will TherapeuticsMD Inc. rebound enough to break evenJuly 2025 Update & AI Driven Price Predictions - Newser
TherapeuticsMD Reports Q2 Profitability, Exceeding 2024 Results - AInvest
TherapeuticsMD Announces Second Quarter 2025 Financial Results - BioSpace
Has TherapeuticsMD Inc. formed a bullish divergence [2025 Winners & Losers]Daily Volume Surge Signals - Newser
TherapeuticsMD Swings to Profit in Q2 - AOL.com
Signal strength of TherapeuticsMD Inc. stock in tech scannersHigh Confidence Strategy with Trend Alignment - Newser
TherapeuticsMD Inc. Rebounds From Oversold Zone — Now WhatConsistent Income Focused Trade List Analyzed - beatles.ru
TherapeuticsMD Reports Q2 2025 Financial Results - TipRanks
How to interpret RSI for TherapeuticsMD Inc. stockDay Trading Setup and Momentum Analysis - Newser
Using flow based indicators on TherapeuticsMD Inc.Price Spike Prediction for Active Traders - Newser
TherapeuticsMD, Inc. SEC 10-Q Report - TradingView
Market reaction to TherapeuticsMD Inc.’s recent newsWeekly Stock Movement Prediction Watchlist - Newser
Regression analysis insights on TherapeuticsMD Inc. performanceStable Swing Setup with Safety Analysis - Newser
Published on: 2025-08-11 03:11:11 - Newser
Is TherapeuticsMD Inc. stock ready for a breakoutLow Drawdown Stock Screener with Analysis - Newser
Published on: 2025-08-11 00:15:37 - Newser
How TherapeuticsMD Inc. stock performs during market volatilityFree Low Risk Equity Screener With Results - Newser
Developing predictive dashboards with TherapeuticsMD Inc. dataBuy List With Technical Entry Triggers - Newser
What recovery options are there for TherapeuticsMD Inc.Free High Growth Low Risk Stock Selection - Newser
What to expect from TherapeuticsMD Inc. in the next 30 daysTrend Confirmation Scanner with Entry Focus - Newser
Does TherapeuticsMD Inc. qualify in momentum factor screeningStable Swing Setup with Safety Analysis - Newser
Is TherapeuticsMD Inc. stock bottoming outShort-Term Price Breakout Signal Analysis - Newser
Therapeuticsmd TXMD 2025Q2 Earnings Preview Upside Potential on New Product Launch - AInvest
Tools to monitor TherapeuticsMD Inc. recovery probabilityROI Focused Watchlist with Trade Confidence - Newser
Why TherapeuticsMD Inc. is moving todayInvestment Position Summary with Timeframe Forecast - Newser
Visual trend scoring systems applied to TherapeuticsMD Inc.Investment Timeline and ROI Summary Report - Newser
TherapeuticsMD (NASDAQ:TXMD) Stock Price Up 0.5% – Should You Buy? - Defense World
TherapeuticsMD Inc. stock trend forecastTechnical Setup Guide for Daily Watchlist - Newser
Will TherapeuticsMD Inc. see short term momentumDaily Breakout List with Smart Filters - Newser
TherapeuticsMD Inc. Company’s Quarterly Earnings Growth: What the Numbers SayTechnical Confirmation System with Signal Alerts - Newser
Traders Watching For Reversal Pattern in TherapeuticsMD Inc.Intraday Trade Ideas - beatles.ru
Therapeuticsmd Inc Azioni (TXMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Therapeuticsmd Inc Azioni (TXMD) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Walker Marlan D | Chief Executive Officer |
Apr 14 '25 |
Buy |
1.00 |
490 |
489 |
73,639 |
| Walker Marlan D | Chief Executive Officer |
Apr 10 '25 |
Buy |
0.86 |
1,167 |
1,000 |
73,149 |
| Walker Marlan D | Chief Executive Officer |
Apr 09 '25 |
Buy |
0.87 |
1,136 |
994 |
71,982 |
| Collins Cooper C. | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
60,516 |
| Naughton Gail K | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
8,500 |
| Thompson Tommy G | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
14,454 |
| Walker Marlan D | Chief Executive Officer |
Feb 18 '25 |
Option Exercise |
0.00 |
8,281 |
0 |
70,846 |
| Collins Cooper C. | Director |
Aug 22 '24 |
Buy |
1.73 |
4,094 |
7,099 |
52,016 |
| Collins Cooper C. | Director |
Aug 21 '24 |
Buy |
1.70 |
1,200 |
2,039 |
47,922 |
4.37%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):